Antibody responses to Sputnik V vaccine in Argentina (IMAGE)

Cell Press

Antibody responses to Sputnik V vaccine in Argentina

Caption

This graphical abstract shows antibody responses to Sputnik V vaccine in Argentina. On the top, schematic representation of the two-component adenovirus based vaccine (rAD26 and rAD5) Sputnik V. Bottom, IgG antibody levels measured by International Units and SARS CoV-2 Neutralizing Titers in vaccinated naïve (seronegative, blue) and previously infected (seropositive, red) volunteers. There is a high seroconversion rate following the first dose in naïve individuals. In previously infected participants, a single dose of Sputnik V elicits a fast and robust antibody response without apparent benefit from a second dose.

Credit

Rossi and Ojeda et al./Cell Reports Medicine

Usage Restrictions

Credit Required.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.